This page is maintained and edited by Hellen Popovich (Senior Editor at World Wide News Flash since May, 2009).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Vivus

July 16, 2010 GSK's Avandia, Obesity-Drug Maker Vivus Go On FDA's Hot Seat Send by PhysiciansMoney The FDA panel ruling on Avandia captured headlines and weighed on shares GlaxoSmithKline this week, but a more decisive panel ruling on Vivus's obesity drug Qnexa more than halved its stock price. Next up: The FDA weighs Arena Pharmaceuticals lorcaserin. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 U.S. Advisers Reject Vivus' Fat Pill | Www.bullfax.com Send by marketmaker (AP) -- A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus' Weight-loss Drug Faces Key U.S. Test (Reuters) : Working ... Posted by Hellen Popovich Vivus' weight-loss drug faces key U.S. test (Reuters). July 15, 2010 by admin. Filed under News Leave a comment. Reuters ? The first potential U.S. prescription weight-loss pill in more than a decade could move closer to market on [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Pharmaceuticals: Vivus Weight-Loss Drug Faces Key US ... Posted by Hellen Popovich Vivus, hoping to bring to market the first new prescription diet drug in more than a decade, told U.S. medical advisers on Thursday that its weight-loss pill gives patients a safe [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Weight-loss Drug Faces Key U.S. Test | Reuters Posted by Hellen Popovich GAITHERSBURG, Maryland (Reuters) - Vivus Inc, hoping to bring to market the first new prescription diet drug in more than a decade, told U.S. medical [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Fails To Win FDA Panel's Recommendation For Weight-Loss Pill Qnexa Send by www.bloomberg.com Vivus Inc. , an unprofitable biotechnology company, failed to win a U.S. panels backing to sell the first new prescription diet pill in more than a decade. Shares of competitors dropped, while Vivus trading was halted. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 U.S. Advisers Reject Vivus' Fat Pill (Reuters) | Eyescoops.ca Send by tristin Reuters - The first new prescription weight-loss pill in more than a decade failed to win backing from US health advisers, who said safety concerns. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 VIVUS Inc. (VVUS) Stock ? Seeking Alpha America Most Wanted Posted by Hellen Popovich Up to date analysis of VIVUS Inc. (VVUS) and its stock by hedge fund manago [...] ers and industry experts. Find out what VIVUS Inc. is saying about its. Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 FDA Rejects Vivus Fat-fighting Pill Qnexa (Reuters) Send by Yahoo! News: Weight Loss News Reuters - Hopes sank that the first new prescription weight-loss pill in more than a decade would be approved for sale when a key federal advisory panel rejected the drug on Thursday amid lingering sa. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Weight Loss Drug Faces Safety Questions - Health & Fitness ... Send by The Associated Press Vivus Inc.'s potential weight loss drug Qnexa will likely draw scrutiny over nervous system and psychiatric side effects from a panel of Food and Drug Administration experts this week. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Arena Pharmaceutical Pop Posted by Hellen Popovich Shares of Arena Pharmaceutical (ARNA) got a nice pop today (up 30% at the moment) following yesterday's announcement that the New England Journal of Medicine would be publishing positive results of the two-year BLOOM (Behavioral Modification and Lorcaserin for Overweight and Obesity Management) tria [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Vivus Obesity Drug Awaiting FDA Review | GDS Publishing Posted by Hellen Popovich Vivus's Qnexa drug, designed to treat obesity, is pending review from the US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, a panel of experts that reviews and evaluates all data regarding [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 U.S. Advisers Reject Vivus' Fat Pill | Reuters Posted by Hellen Popovich GAITHERSBURG, Maryland (Reuters) - The first new prescription weight-loss pill in more than a decade failed to win backing from U.S. health advisers, who said safety concerns about [...] Rating: No stars. Rate up / Rate down Report to moderator

July 16, 2010 Eclipsys, Landstar, Mylan, Opnet, Taleo, Veeco, Vivus: U.S. Equity ... Send by Trade Futures Online Eclipsys, Landstar, Mylan, Opnet, Taleo, Veeco, Vivus: US Equity Preview Shares of the following companies may have unusual moves in US trading tomorrow. [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Tough Out There ... Posted by Hellen Popovich The action of the past couple days reminds me a lot of the early part of this year, when the market would go up and down but finish relatively flat, much to the frustration of people who are short like me. I mean that literally and figuratively. [Note: Watching the World Cup made me realize I should [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 Healthy Diet Tips Vivus Tanks, Arena Rallies On FDA Diet-drug ... Posted by Hellen Popovich Vivus tanks, Arena rallies on FDA diet-drug vote MarketWatch ? day after a US Food and Drug advisory panel refused to recommend the agency approve the company's new diet drug Qnexa due to certain safety concerns. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 16, 2010 VIVUS Inc. Is Down Sharply Following FDA Adivsory Panel Rejection Send by www.rttnews.com VIVUS Inc. (VVUS) announced after the bell Thursday that an FDA advisory committee voted against the approval of Qnexa for the treatment of obesity. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.